New York State Common Retirement Fund Has $66.66 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

New York State Common Retirement Fund lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 880,438 shares of the company’s stock after selling 12,939 shares during the period. New York State Common Retirement Fund’s holdings in Henry Schein were worth $66,658,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Xponance Inc. boosted its holdings in Henry Schein by 2.1% in the third quarter. Xponance Inc. now owns 21,839 shares of the company’s stock worth $1,622,000 after acquiring an additional 443 shares in the last quarter. Everett Harris & Co. CA boosted its holdings in Henry Schein by 29.1% in the fourth quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock worth $7,925,000 after acquiring an additional 23,622 shares in the last quarter. Sprucegrove Investment Management Ltd. boosted its holdings in Henry Schein by 14.2% in the fourth quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after acquiring an additional 27,500 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Henry Schein by 215.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 74,251 shares of the company’s stock worth $5,622,000 after acquiring an additional 50,723 shares in the last quarter. Finally, Caxton Associates LP boosted its holdings in Henry Schein by 80.8% in the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock worth $1,410,000 after acquiring an additional 8,486 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity

In other news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Up 1.0 %

Shares of HSIC stock opened at $72.76 on Wednesday. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average price of $74.30 and a two-hundred day moving average price of $72.44. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $85.39. The firm has a market cap of $9.35 billion, a P/E ratio of 23.10, a price-to-earnings-growth ratio of 1.79 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period last year, the firm posted $1.21 EPS. The company’s revenue was down 10.5% on a year-over-year basis. Equities analysts anticipate that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HSIC. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. JPMorgan Chase & Co. lifted their price target on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Barrington Research lifted their price target on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, February 28th. SVB Leerink started coverage on Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. Finally, Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $81.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.